If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLVD.L Regulatory News (LVD)

  • There is currently no data for LVD

Form 8.3 - Lavendon Group PLC

29 Dec 2016 08:33

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the β€œCode”)

1. KEY INFORMATION

(a) Full name of discloser: Sand Grove Capital Management LLP as investment manager acting on behalf of Sand Grove Opportunities Master Fund LTD
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Lavendon Group PLC
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

28 December 2016
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state β€œN/A”

No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled:
(2) Cash-settled derivatives: 9,315,737 5.48
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:

9,315,737 5.48

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security Purchase/sale Number of securities Price per unit

(b) Cash-settled derivative transactions

Class of relevant security Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities Price per unit
Ordinary CFD Increasing a long position 400,000 263.045

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state β€œnone”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state β€œnone”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? No
Date of disclosure: 29 December 2016
Contact name: Daniel McLachlan
Telephone number: +44 (0) 203 770 8617

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161229005123/en/

Copyright Business Wire 2016

Date   Source Headline
13th Mar 20157:00 amRNSHolding(s) in Company
12th Mar 20153:26 pmRNSDirector/PDMR Shareholding
6th Mar 20153:14 pmRNSTotal Voting Rights
5th Mar 20154:54 pmRNSTR-1: Notification of Major Interest in Shares
26th Feb 20157:01 amRNSPreliminary Results
25th Feb 20155:21 pmRNSDirector Declaration
19th Feb 201511:25 amRNSHolding(s) in Company
2nd Feb 20155:10 pmRNSTotal Voting Rights
30th Jan 20151:57 pmRNSHolding(s) in Company
21st Jan 20155:17 pmRNSHolding(s) in Company
15th Jan 20157:00 amRNSFull Year Trading Update
5th Jan 20151:50 pmRNSTotal Voting Rights
1st Dec 20144:00 pmRNSTotal Voting Rights
20th Nov 20143:08 pmRNSHolding(s) in Company
18th Nov 20147:00 amRNSInterim Management Statement
7th Nov 20147:00 amRNSNotice of Interim Management Statement
3rd Nov 201410:10 amRNSTotal Voting Rights
14th Oct 20149:16 amRNSDirector/PDMR Shareholding REPLACEMENT
13th Oct 20144:15 pmRNSDirector/PDMR Shareholding
7th Oct 20147:00 amRNSAdditional Listing
6th Oct 20145:33 pmRNSTotal Voting Rights
2nd Sep 201411:04 amRNSTotal Voting Rights
29th Aug 20147:00 amRNSHalf Year Results
29th Aug 20147:00 amRNSAgreement of New Debt Facilities
4th Aug 201412:19 pmRNSTotal Voting Rights
10th Jul 20147:00 amRNSFirst Half Trading Update
2nd Jul 20141:34 pmRNSDirector/PDMR Shareholding
1st Jul 20143:48 pmRNSTotal Voting Rights
17th Jun 20142:45 pmRNSHolding(s) in Company
10th Jun 20149:00 amRNSCapital Markets Day
2nd Jun 20145:08 pmRNSTotal Voting Rights
23rd May 201411:39 amRNSDirector Declaration
19th May 20144:18 pmRNSHolding(s) in Company
1st May 20144:17 pmRNSTotal Voting Rights
1st May 20143:28 pmRNSDirector and PDMR Announcement
22nd Apr 20147:01 amRNSAdditional Listing
17th Apr 20141:41 pmRNSResult of AGM
17th Apr 20147:00 amRNSInterim Management Statement
11th Apr 20149:37 amRNSDIRECTORS PDMR SHAREHOLDINGS
10th Apr 20142:57 pmRNSHolding(s) in Company
7th Apr 20149:52 amRNSHolding(s) in Company
12th Mar 20142:18 pmRNSHolding(s) in Company
4th Mar 20149:36 amRNSTotal Voting Rights
27th Feb 20147:00 amRNSBoard Changes
27th Feb 20147:00 amRNSPreliminary Results
3rd Feb 20144:39 pmRNSTotal Voting Rights
16th Jan 20147:00 amRNSFull Year Trading Update 2013
7th Jan 20143:06 pmRNSTotal Voting Rights
14th Nov 20137:00 amRNSInterim Management Statement
1st Nov 201310:04 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.